![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](sj2595contents.gif)
Acta Cryst. (2009). E65, m418 [ doi:10.1107/S1600536809009234 ]
Abstract: The title compound, [Zn(C13H16BrN2O2)I(CH3OH)], is a new mononuclear zinc(II) complex synthesized by the reaction of equimolar quantities of 5-bromosalicylaldehyde, 2-morpholinoethylamine and ZnI2 in methanol. The Zn atom is four-coordinate in a distorted tetrahedral geometry, binding to a phenolate O and an imine N atom of the Schiff base ligand, the O atom of a methanol molecule and one I- anion. In the crystal structure, adjacent molecules are linked through intermolecular O-H
O hydrogen bonds, forming centrosymmetric dimers.
Online 19 March 2009
Copyright © International Union of Crystallography
IUCr Webmaster